secwatch.observer — SEC 8-K summary
======================================

Issuer:     Kiniksa Pharmaceuticals International, plc (KNSA)
CIK:        0001730430
Form:       8-K
Filed at:   2024-06-05T23:59:59+00:00
Accession:  0001104659-24-068694
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Kiniksa shareholders approve redomiciliation scheme; court sanction hearing set for June 14
--------------------------------------------------------------------------------

- Scheme of arrangement approved by 61,460,949 votes for, 501,355 against, 274,060 abstained.
- Supreme Court of Bermuda sanction hearing expected on or around June 14, 2024 at 9:30 a.m. AST.
- At annual meeting, directors Felix J. Baker, Tracey L. McCain, Kimberly J. Popovits re-elected; auditor PwC ratified; say-on-pay passed.
- Redomiciliation meeting was held immediately after annual meeting per Bermuda court order dated April 19, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1730430/000110465924068694/0001104659-24-068694-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1730430/000110465924068694/tm2416534d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-068694

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer